CRDL
Cardiol Therapeutics·NASDAQ
--
--(--)
--
--(--)
CRDL Filings
Filing Date
Form Description
Form Type
2026-02-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-30
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-30 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-26 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-16
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-16 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-01
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-01 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-11-13 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-05
Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
2025-11-05 ·
Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
